Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 + 1973 word(s) 1973 2022-02-11 09:08:05 |
2 format correct -50 word(s) 1923 2022-02-28 02:12:29 | |
3 format correct -50 word(s) 1923 2022-02-28 02:14:04 | |
4 format correct Meta information modification 1923 2022-02-28 07:58:12 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Feás, X. Sting-Related Deaths in Europe (1994–2016). Encyclopedia. Available online: https://encyclopedia.pub/entry/19912 (accessed on 15 November 2024).
Feás X. Sting-Related Deaths in Europe (1994–2016). Encyclopedia. Available at: https://encyclopedia.pub/entry/19912. Accessed November 15, 2024.
Feás, Xesús. "Sting-Related Deaths in Europe (1994–2016)" Encyclopedia, https://encyclopedia.pub/entry/19912 (accessed November 15, 2024).
Feás, X. (2022, February 25). Sting-Related Deaths in Europe (1994–2016). In Encyclopedia. https://encyclopedia.pub/entry/19912
Feás, Xesús. "Sting-Related Deaths in Europe (1994–2016)." Encyclopedia. Web. 25 February, 2022.
Sting-Related Deaths in Europe (1994–2016)
Edit

Bees and wasps provide an important service to ecosystems, contributing to the improvement of biodiversity while helping to maintain ecological balance. Although not frequent, hornet, wasp, and bee stings may be life-threatening. With each sting, Hymenopterans inject a small amount of venom that can cause reactions of varying intensity: (i) normal local reactions (NLR), (ii) large local reactions (LLR), (iii) systemic anaphylactic reactions (SAR), (iv) systemic toxic reactions (STR) and (v) unusual reactions (UR).  Hymenopteran stings have recently become a worldwide public health concern. However, this health problem can be underestimated despite the number of cases presented. With the expansion of non-native Hymenopteran species across Europe, allergists should be aware that their community’s exposures are continually changing.

Hymenoptera insect bee wasp hornet epidemiology fatalities venomous animals public health

1. Introduction

Anaphylaxis is an acute, life-threatening reaction that occurs shortly after contact with a trigger. It is classically defined as the most severe form of an allergic reaction, but it could also be induced by non-IgE-mediated pathways through the activation of mast cells and basophils through different mechanisms [1]. Common triggers of anaphylaxis include foods, drugs, venoms from insects, general anaesthetics, radiocontrast agents, and latex, among others, and their prevalence varies from region to region being different for each patient group [2].
The medically important groups of the Hymenoptera order in Europe are those of the genus Apis and Bombus (belonging to the family Apidae), and VespulaDolichovespulaVespa and Polistes (family Vespidae) [3]. Social Apidae, Vespinae and Polistinae possess a large and comprehensive array of venom components [4]. Hymenoptera venoms are composed of a mixture of biologically active proteins and peptides, some of them common to different species such as phospholipases, hyaluronidase, phosphatase, α-glucosidase, serotonin, histamine, dopamine, noradrenaline, and adrenaline. Other proteins such as melittin, apamin, and the mast cell degranulating peptide are exclusive to bees, while mastoparan and bradykinin are only found in wasps [5][6][7][8][9][10]. As a rule, Hymenoptera species are not especially predisposed to attack humans; however, social hornets, wasps, and bees have developed a protective response to whatever risk the colony faces through stings.
With each sting, Hymenopterans inject a small amount of venom that can cause reactions of varying intensity: (i) normal local reactions (NLR), (ii) large local reactions (LLR), (iii) systemic anaphylactic reactions (SAR), (iv) systemic toxic reactions (STR) and (v) unusual reactions (UR) [11]. The local reaction is limited to the area of the sting and is usually small in size, with redness, swelling and intense pain. If a person has a reaction area of the sting of greater than 10 cm, it may mean that he or she has been sensitized, but, as a rule, it does not need any special action. SAR reactions are those that cause symptoms beyond the point of the sting and can range from skin lesions to respiratory problems, digestive symptoms or anaphylaxis. The prevalence of SAR in Europe due to Hymenoptera stings ranged between 0.3 and 7.5% in adults and is slightly lower in children (0.15–3.4%) [12]. STR occur due to multiple Hymenoptera stings because of the well-known toxic properties of their venoms. The symptomatology of UR differs from typical allergic reactions, and, in some cases, follow-up is required over many months [13].
Some authors indicated that 94.5% of humans are stung by Hymenoptera insects at some point in their lifetime [14]. Although most of these stings are not reported, general practitioners attend to a large number of patients with Hymenoptera stings, and a few of them require rapid assistant at emergency departments. Thus, in USA, it was estimated that 220,000 annual visits are made to the emergency department and nearly 60 deaths occur per year due to Hymenopteran stings [15]. In addition, an analysis of 4000 cases of anaphylaxis from Germany, Austria and Switzerland, show insect venom (n = 2074; 50.1%) as a common trigger of anaphylaxis [2]. For these reasons, researchers highlight that an effective and affordable treatment for anaphylaxis caused by these arthropods is critical.
Hymenopteran stings have recently become a worldwide public health concern [16][17]. However, this health problem can be underestimated despite the number of cases presented. Realistic mortality epidemiological data are still lacking in some countries [18]. Information on the incidence of fatalities due Hymenoptera stings is crucial for an assessment of the problem, as well as to enhance medical assistance for patients and creating public policies aimed at decreasing the incidence of these events [19][20]. More than half of the people with fatal sting reactions had no preceding anaphylactic episodes [21][22].
According to chapter XX of the International Classification of Diseases and Related Health Problems 10th Revision (ICD-10) fatalities due to hornet, wasp and bee stings (including yellow jackets) are coded as X23 [23]. The worldwide incidence of insect-sting mortality ranged from 0.03 to 0.48 fatalities per 1,000,000 inhabitants per year, which is low but not negligible [21].

2. Hymenopteran Sting-Related Deaths

During 1994–2016, a total of 1691 deaths were officially registered in Europe with code X23. Fatalities were confirmed in 28 countries, with Germany (n = 327, 19.3%), France (n = 211, 12.5%) and Romania (n = 149, 8.8%) reporting the highest numbers (Table 1). A total of eleven countries (BG, FR, DE, EL, IT, PL, RO, RS, ES, CH and UK) report deaths every year. FR, DE, EL, PL and RO, had the minimum number of such deaths. At least one sting-related death occurred yearly in the following six countries: BG, IT, RS, ES, CH and UK. In the rest of the countries (n = 17), deaths due to stings of Hymenoptera insects are not always present. The maximum values of the number of annual deaths for the different countries, varied, ranking as: DE (32), FR (23), RO (16), CZ (14), HU (13); and AT, IT and FL (12). The range of deaths varies from country to country, at it is interesting to highlight the following: DE (range = 26); CZ, FR and RO (range = 14); HU (range = 13); AT (range = 12) and IT (range = 11).
Table 1. Descriptive statistics of fatalities due to hornet, wasp and bee stings by country (1994–2016).
Country 1 Size Sum Minimum Maximum Range Mode Mean Median Standard Deviation Variance
AT 15 73 0 12 12 5 4.87 5 3.27 10.7
BE 18 27 0 5 5 1 1.5 1 1.42 2.03
BG 9 26 1 6 5 2 2.89 2 1.62 2.61
HR 19 35 0 6 6 1 1.84 1 1.71 2.92
CZ 23 111 0 14 14 4 4.83 4 3.04 9.24
EE 17 14 0 3 3 0 0.82 1 1.01 1.03
FI 20 25 0 4 4 0 1.25 1 1.25 1.57
FR 15 211 9 23 14 14 14.07 14 4.15 17.21
DE 18 327 6 32 26 18 18.17 18 6.97 48.62
EL 2 9 4 5 1 4 & 5 4.5 4.5 0.71 0.5
HU 21 112 0 13 13 4 5.33 4 3.54 12.53
IE 8 2 0 1 1 0 0.25 0 0.46 0.21
IT 13 69 1 12 11 5 & 3 5.31 5 3.4 11.56
LV 9 9 0 2 2 2 1 1 1 1
LT 7 7 0 4 4 1 & 0 1 1 1.41 2
LU 7 1 0 1 1 0 0.14 0 0.38 0.14
NL 21 20 0 5 5 0 0.95 1 1.2 1.45
NO 20 19 0 3 3 1 0.95 1 0.76 0.58
PL 17 125 3 12 9 7 & 8 & 9 7.35 8 2.67 7.12
PT 13 9 0 4 4 0 0.69 0 1.32 1.73
RO 18 149 2 16 14 10 8.28 9 3.44 11.86
RS 18 53 1 6 5 3 2.94 3 1.43 2.06
SK 21 17 0 2 2 0 0.81 1 0.81 0.66
SI 19 21 0 4 4 0 1.11 1 1.37 1.88
ES 17 60 1 8 7 4 & 3 3.53 3 1.81 3.26
SE 20 44 0 6 6 1 2.2 2 1.61 2.59
CH 21 65 1 8 7 4 3.1 3 1.61 2.59
UK 15 51 1 7 6 2 3.4 4 1.84 3.4
1 There are not registered deaths due to hornet, wasp and bee stings in: Iceland (1996–2016), Malta (1995–2004), Montenegro (1999–2004) and Bosnia and Herzegovina (2011).

3. Specific Locations where Hymenopteran Sting-Related Deaths Occurred

The X23 code extension to four-digit is fully available for most of the countries, with a total of 18 reporting case details. Conversely, three countries (FI, LV and SI) report all deaths without the four-digit extension. In seven countries (BE, BG, EE, LT, RS, SK and SE) both the X23 code with and without an extension to four-digit are used. All countries register the highest number of deaths with the code X23.9 (unspecified place), except for Hungary, and Austria, where the code X23.0 (home) harbours the highest number of Hymenopteran sting-related death events. In general, the pattern observed for most countries, with a few exceptions is X23.9 > X23.0 > X23.8 >X23.4 > X23.7; with no recorded deaths labelled as X23.5 (trade and service area). Very little used codes are: (i) 1 death coded as X23.3 (sports and athletics area) and 1 death coded as X23.6 (industrial and construction area), both having place in Romania; and (ii) seven deaths coded as X23.2 (school, other institution and public administrative area) in Belgium (1), Czechia (1), Hungary (3), Poland (1) and Spain (1); and 8 deaths coded as X23.1 (residential institution) in Austria (1), Belgium (1), Czechia (3), Norway (1) and Poland (2).

4. Age Distribution of Hymenopteran Sting-Related Deaths

Adults (25–64 years) were the most common age group to be fatally injured by Hymenopteran stings. Lithuania is the only exception, with an equal rate of adults and seniors (65 years and older) Hymenopteran sting-related deaths, a total of three. Only adult deaths were found in the following two countries: Ireland and Luxembourg. Children (0–14 years) fatalities were recorded in six countries: FR (2), RO (2), AT (1), HR (1), PT (1), and SK (1). A total of 22 victims in the youth group (15–24 years) were recorded in 12 countries with the following distribution: RO (6), AT (3), HU (2) and CH (2), and CZ, FR, DE, IT, LT, PL, RS and SI with only one death.

5. Hymenopteran Sting-Related Deaths by Gender

The majority of deaths (n = 1691) in Europe occurred in males. In fact, there are four countries with only male deaths, specifically, Greece and Portugal with nine male victims each; and Ireland and Luxembourg with two and one male victims, respectively. The X23 gender ratio (X23GR) of mortality varied from a min value of 1.4 for Norway to a maximum value of 20 for Slovenia, with a range of 18.6 for the whole dataset of countries. Obtained values for the calculated X23 gender differential (X23GD) varied between countries, being over 100 in Germany, France and Romania, with values of 157, 113 and 111, respectively.

6. Hymenopteran Sting-Related Deaths Features by Region: Eastern, Northern, Southern and Western Europe

Fatalities mostly occurred in Western (42.8%), Eastern (31.9%), Southern (15.1%) and Northern Europe (10.1%). Both X23GR and X23GD varied for the four regions, as follows: X23GD [Western Europe (366), Eastern Europe (310), Southern Europe (190) and Northern Europe (83)] and X23GR [Southern Europe (6.8), Eastern Europe (3.7), Western Europe (3.0) and Northern Europe (2.9)] (Table 2). Results show that eight and twenty-one fatalities were recorded in children (0–14 years) and the youth group (15–24 years), respectively. Adults (25–64 years) and seniors (65 years and older) were the most common age groups to be fatally injured with a total of 1128 victims (66.7%) and 520 victims (30.8%), respectively (Table 2). Fatal stings occurred mainly at home (29.4%) and at other specified places (11.2%), followed by on the street and highway (3.2%) and at farms (1.5%). However, 44.2% of the fatalities, a total of 748, are recorded at an “unspecified place”. The ranked order of the place of ocurrence was: X23.9 (unspecified place) > X23.0 (home) > X23.8 (other specified places) for Europe and Northern Europe; X23.0 (home) > X23.9 (unspecified place) > X23.8 (other specified places) for Eastern Europe; and X23.9 (unspecified place) > X23.8 (other specified places) > X23.0 (home) for Southern Europe.
Table 2. Absolute and relative frequency of the deaths due to hornet, wasp and bee stings in Europe and by European region: counts, X23 gender ratio of mortality (X23GR), X23 gender differential in mortality (X23GD), by age distribution and by place of occurrence.
Items Items Eastern Europe 1
1994–2016
Northern Europe 2
1996–2016
Southern Europe 3
1995–2015
Western Europe 4
1995–2016
Europe
1994–2016
Deaths Total 540 171 256 724 1691
  Men 425
(78.7%)
127
(74.3%)
223
(87.1%)
545
(75.3%)
1320
(78.1%)
  Woman 115
(21.3%)
44
(25.7%)
33
(12.9%)
179
(24.7%)
371
(21.9%)
Ratio X23GR 3.7 2.9 6.8 3 3.6
  X23GD 310 83 190 366 949
Age ≤14 years 3
(0.6%)
- 2
(0.8%)
3
(0.4%)
8
(0.5%)
  15–24 years 10
(1.9%)
1
(0.6%)
3
(1.2%)
7
(1%)
21
(1.2%)
  25–64 years 418
(77.4%)
101
(59.1%)
169
(66%)
440
(60.8%)
1128
(66.7%)
  ≥65 years 109
(20.2%)
55
(32.2%)
82
(32%)
274
(37.8%)
520
(30.8%)
Place Not reported 33
(6.1%)
52
(30.4%)
73
(28.5%)
1
(0.1%)
159
(9.4%)
  X23 code extension to four-digit reported 5 507
(93.9%)
119
(69.6%)
183
(71.5%)
723
(99.9%)
1532
(90.6%)
  X23.0 (home) 241
(44.6%)
35
(20.5%)
19
(7.4%)
202
(27.9%)
497
(29.4%)
  X23.1 (residential institution) 5
(0.9%)
1
(0.6%)
- 2
(0.3%)
8
(0.5%)
  X23.2 (school, other institution and public administrative area) 5
(0.9%)
- 1
(0.4%)
1
(0.1%)
7
(0.4%)
  X23.3 (sports and athletics area) 1
(0.2%)
- - - 1
(0.1%)
  X23.4 (street and highway) 17
(3.1%)
1
(0.6%)
6
(2.3%)
30
(4.1%)
54
(3.2%)
  X23.5 (trade and service area) - - - - -
  X23.6 (industrial and construction area) 1
(0.2%)
- - - 1
(0.1%)
  X23.7 (farm) 18
(3.3%)
1
(0.6%)
6
(2.3%)
1
(0.1%)
26
(1.5%)
  X23.8 (other specified place) 48
(8.9%)
9
(5.3%)
21
(8.2%)
112
(15.5%)
190
(11.2%)
  X23.9 (unspecified place) 171
(31.7%)
72
(42.1%)
130
(50.8%)
375
(51.8%)
748
(44.2%)
1 Eastern Europe (n = 6): BG, CZ, HU, PL, RO and SK. 2 Northern Europe (n = 9): EE, FI, IS, IE, LV, LT, NO, SE and UK. 3 Southern Europe (n = 10): BA, HR, EL, IT, MT, ME, PT, RS, SI and ES. 4 Western Europe (n = 7): AT, BE, FR, DE, LU, NL, and CH. 5 

7. Hymenopteran Sting-Related Deaths, X23 Mortality Rates (X23MR)

The mortality rates (X23MR) were calculated based on the population size of each country, the obtained results ranged from 0 to 2.24 with an average of 0.26. The country with the highest mean X23MR was Estonia (0.61) followed by Austria and Slovenia (0.6 and 0.55, respectively). The countries with the lowest X23MR values were Ireland (0.05), United Kingdom (0.06) and the Netherlands (0.06). The highest rates were recorded in countries from Eastern Europe (X23MR = 0.35) followed by Western (X23MR = 0.28), Northern (X23MR = 0.23) and Southern (X23MR = 0.2) Europe (Figure 1).
Figure 1. Map of Europe showing the average Hymenopteran sting-related mortality rates (X23MR) during the studied period (1994–2016). The X23MR are expressed in terms of annual rates (i.e., per year) and per 1,000,000 inhabitants, based in the dataset range for each country.

References

  1. Cianferoni, A. Non-IgE-mediated anaphylaxis. J. Allergy Clin. Immunol. 2021, 147, 1123–1131.
  2. Worm, M.; Eckermann, O.; Dölle, S.; Aberer, W.; Beyer, K.; Hawranek, T.; Hompes, S.; Koehli, A.; Mahler, V.; Nemat, K.; et al. Triggers and treatment of anaphylaxis: An analysis of 4000 cases from Germany, Austria and Switzerland. Dtsch. Arztebl. Int. 2014, 111, 367–375.
  3. Demain, J.G.; Minaei, A.A.; Tracy, J.M. Anaphylaxis and insect allergy. Curr. Opin. Allergy Clin. Immunol. 2010, 10, 318–322.
  4. Yoon, K.A.; Kim, K.; Kim, W.-J.; Bang, W.Y.; Ahn, N.-H.; Bae, C.-H.; Yeo, J.-H.; Lee, S.H. Characterization of venom components and their phylogenetic properties in some Aculeate bumblebees and wasps. Toxins 2020, 12, 47.
  5. Pucca, M.B.; Cerni, F.A.; Oliveira, I.S.; Jenkins, T.P.; Argemí, L.; Sørensen, C.V.; Ahmadi, S.; Barbosa, J.E.; Laustsen, A.H. Bee updated: Current knowledge on bee venom and bee envenoming therapy. Front. Immunol. 2019, 10, 2090.
  6. Pak, S.C. An introduction to the toxins special issue on “bee and wasp venoms: Biological characteristics and therapeutic application”. Toxins 2016, 8, 315.
  7. Feindor, M.; Heath, M.D.; Hewings, S.J.; Carreno Velazquez, T.L.; Blank, S.; Grosch, J.; Jakob, T.; Schmid-Grendelmeier, P.; Klimek, L.; Golden, D.B.K.; et al. Venom immunotherapy: From proteins to product to patient protection. Toxins 2021, 13, 616.
  8. Perez-Riverol, A.; Justo-Jacomini, D.L.; Zollner, R.D.L.; Brochetto-Braga, M.R. Facing hymenoptera venom allergy: From natural to recombinant allergens. Toxins 2015, 7, 2551–2570.
  9. Pascoal, A.; Estevinho, M.M.; Choupina, A.B.; Sousa-Pimenta, M.; Estevinho, L.M. An overview of the bioactive compounds, therapeutic properties and toxic effects of apitoxin. Food Chem. Toxicol. 2019, 134, 110864.
  10. Abd El-Wahed, A.; Yosri, N.; Sakr, H.H.; Du, M.; Algethami, A.F.M.; Zhao, C.; Abdelazeem, A.H.; Tahir, H.E.; Masry, S.H.D.; Abdel-Daim, M.M.; et al. Wasp venom biochemical components and their potential in biological applications and nanotechnological interventions. Toxins 2021, 13, 206.
  11. Elieh Ali Komi, D.; Shafaghat, F.; Zwiener, R.D. Immunology of bee venom. Clin. Rev. Allergy Immunol. 2018, 54, 386–396.
  12. Sahiner, U.M.; Durham, S.R. Hymenoptera venom allergy: How does venom immunotherapy prevent anaphylaxis from bee and wasp stings? Front. Immunol. 2019, 10, 1959.
  13. Mingomataj, E.Ç.; Bakiri, A.H.; Ibranji, A.; Sturm, G.J. Unusual reactions to hymenoptera stings: What should we keep in mind? Clin. Rev. Allergy Immunol. 2014, 47, 91–99.
  14. Nittner-Marszalska, M.; Cichocka-Jarosz, E. Insect sting allergy in adults: Key messages for clinicians. Pol. Arch. Med. Wewn. 2015, 125, 929–937.
  15. Forrester, J.A.; Weiser, T.G.; Forrester, J.D. An update on fatalities due to venomous and nonvenomous animals in the United States (2008–2015). Wilderness Environ. Med. 2018, 29, 36–44.
  16. Ferreira, R.S., Jr.; Almeida, R.A.; Barraviera, S.R.; Barraviera, B. Historical perspective and human consequences of Africanized bee stings in the Americas. J. Toxicol. Environ. Health B Crit. Rev. 2012, 15, 97–108.
  17. Herrera, C.; Leza, M.; Martínez-López, E. Diversity of compounds in Vespa spp. venom and the epidemiology of its sting: A global appraisal. Arch. Toxicol. 2020, 94, 3609–3627.
  18. Tanno, L.K.; Calderon, M.A.; Smith, H.E.; Sanchez-Borges, M.; Sheikh, A.; Demoly, P.; Joint Allergy Academies. Dissemination of definitions and concepts of allergic and hypersensitivity conditions. World Allergy Organ. J. 2016, 9, 24.
  19. Linard, A.T.S.; Barros, R.M.; Sousa, J.A.; Leite, R.S. Epidemiology of bee stings in Campina Grande, Paraíba state, Northeastern Brazil. J. Venom. Anim. Toxins Incl. Trop. Dis. 2014, 20, 13.
  20. Golden, D.B.; Demain, J.; Freeman, T.; Graft, D.; Tankersley, M.; Tracy, J.; Blessing-Moore, J.; Bernstein, D.; Dinakar, C.; Greenhawt, M.; et al. Stinging insect hypersensitivity: A practice parameter update 2016. Ann. Allergy Asthma Immunol. 2017, 118, 28–54.
  21. Bilò, M.B.; Bonifazi, F. The natural history and epidemiology of insect venom allergy: Clinical implications. Clin. Exp. Allergy 2009, 39, 1467–1476.
  22. Biló, B.M.; Rueff, F.; Mosbech, H.; Bonifazi, F.; Oude-Elberink, J.N.; EAACI Interest Group on Insect Venom Hypersensitivity. Diagnosis of hymenoptera venom allergy. Allergy 2005, 60, 1339–1349.
  23. International Statistical Classification of Diseases and Related Health Problems (Icd-10) Version: 2019. Available online: https://icd.who.int/browse10/2019/en (accessed on 11 May 2021).
More
Information
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
View Times: 1.1K
Revisions: 4 times (View History)
Update Date: 28 Feb 2022
1000/1000
ScholarVision Creations